Damian T.
- Country
- Poland
- Department
- Oddział Kliniczny Pulmonologii Ogolnej i Onkologicznej
Research Overview
Data & Insights
Has run more than one trial at 0 of 29 partner sites.
Specializations
Lung Cancer Therapeutics
The investigator specializes in treating advanced non-small cell lung cancer (NSCLC), with particular focus on cases involving specific genetic mutations.
- HER2 (ERBB2) mutation positive NSCLC
- EGFR mutation positive NSCLC
- Metastatic NSCLC
The investigator explores innovative therapeutic approaches for treating lung cancer patients with targeted molecular characteristics.
Precision Oncology
Expertise in targeted therapy development for specific genetic alterations in lung cancer, focusing on personalized treatment approaches.
- Growth factor receptor targeting
- Novel therapeutic compounds
- Combination therapy strategies
The investigator evaluates emerging treatments targeting specific molecular pathways in cancer progression.
Treatment Evaluation
Focuses on assessing therapeutic efficacy through key clinical outcomes in advanced lung cancer treatment.
- Progression-free survival assessment
- Overall survival evaluation
- Comparative treatment analysis
The investigator conducts systematic evaluations of novel therapeutics against standard treatment options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.